Echo Therapeutics

Echo Therapeutics launches diabetes study

Thursday, October 13, 2011

Echo Therapeutics has initiated a clinical study of its Symphony tCGM System in patients with type 1 and type 2 diabetes. The company expects to complete and announce the results of the study in the fourth quarter, and plans to subsequently begin a separate study in critical care patients.

[Read More]